Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Order Online! Now! Get your $50 coupon for online order.Order Online! Now! Get your $50 coupon for online order.
Request a FREE sample of our GMP products! Request a FREE sample of our GMP products!
Fill out organ-on-a-chip questionnaire to win a FREE gift! Fill out organ-on-a-chip questionnaire to win a FREE gift!
About the Immuno-Oncology Summit
Over the past 8 years, CHI's Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research, providing comprehensive and in-depth coverage across all modalities and stages in the pipeline. Every year, CHI assembles an international mix of thought leaders and decision makers from industry and academia to bring you the latest developments in immuno-oncology, while providing access to a comprehensive 3-day program and extensive networking opportunities that CHI's IO Summit provides.
ACRO’s talk
Day One: October 6th, 11:50am EDT
Program: Bispecific Antibodies for Cancer Immunotherapy
Talk Tittle: The crucial role of high-quality CD3 protein in the development of anti-CD3 bispecific antibodies
Highlights:
1. Bispecific antibodies (bsAbs) are promising immunotherapeutic agents for cancer therapy.
2. A common clinical application of bsAbs is retargeting T cells to kill tumor cells by targeting CD3 protein.
3. High-quality recombinant CD3 protein is required to develop and screen the functional bsAbs candidates.
4. A variety of CD3 proteins from different species and with various tags can accelerate the development of anti-CD3 bsAbs.
5. The validation of bioactivity of CD3 protein is conducted by measure the binding affinity between recombinantly produced CD3 protein and clinical anti-CD3 bsAbs.
Speaker: Yinan Jiang, Ph.D.
Product Development Manager at ACROBiosystems Inc.
This web search service is supported by Google Inc.